The substrate maintaining persistent atrial fibrillation.
Haïssaguerre
Michel
M
Wright
Matthew
M
Hocini
Mélèze
M
Jaïs
Pierre
P
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000503:physiopathology / Q000601:surgery*; D017115:Catheter Ablation / Q000009:adverse effects; D054326:Coronary Sinus / Q000503:physiopathology / Q000601:surgery; D004554:Electric Countershock; D022062:Electrophysiologic Techniques, Cardiac; D006325:Heart Atria / Q000503:physiopathology / Q000601:surgery; D006801:Humans; D018579:Patient Selection; D012008:Recurrence; D012086:Reoperation; D013997:Time Factors; D016896:Treatment Outcome
D000889:Anti-Arrhythmia Agents